Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts

Article ID	Journal	Published Year	Pages	File Type
5705615	Ophthalmology	2016	10 Pages	PDF

Abstract

This RCT demonstrated safe and sustained 2-year reduction in IOP and glaucoma medication use after microinterventional surgical treatment for mild-to-moderate POAG.

Keywords

FDA MIGS IOL BCVA iOp OAG POAG RCT Randomized controlled trial ITT best-corrected visual acuity Per-protocol Food and Drug Administration adverse event confidence interval Intraocular pressure intention-to-treat intraocular lens Open-angle glaucoma primary open-angle glaucoma

Related Topics

Health Sciences Medicine and Dentistry Ophthalmology

Preview

Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts

Authors

Steven MD, Iqbal Ike K. MD, E. Randy MD, Cynthia MD, Robert MD, Mark MD, Reay H. MD, Tsontcho MD, MPH, CyPass Study Group CyPass Study Group,